Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report
Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report. // Heliyon. – URL: https://www.sciencedirect.com/science/article/pii/S2405844026011503?dgcid=rss_sd_all
Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report. Heliyon. https://www.sciencedirect.com/science/article/pii/S2405844026011503?dgcid=rss_sd_all
“Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report.” Heliyon.
@article{article28153,
title = {Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report},
journal = {Heliyon},
url = {https://www.sciencedirect.com/science/article/pii/S2405844026011503?dgcid=rss_sd_all}
}